ELOX logo

Eloxx Pharmaceuticals, Inc.

ELOX
Healthcare|Biotechnology|US
$12.44
-0.36 (-2.81%)
DCF Value
$1.22
Tangible Book / Share
$6.84
Cash / Share
$9.13
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Oct 22, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Jun 2027
Est. completion
P2Alport Syndrome, X-Linked
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety
NCT07523581n=24

Recent Press Releases

Eloxx Pharmaceuticals to Present at the 3rd Annual Guggenheim Healthcare Innovation Conference
Nov 2, 2026 · PRNewsWire
Eloxx Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Exaluren in Nonsense-Mutation ADPKD
Oct 29, 2026 · PRNewsWire
Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D.
Oct 20, 2026 · PRNewsWire
Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
Oct 19, 2026 · PRNewsWire
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
Sep 11, 2026 · PRNewsWire
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 12, 2026 · PRNewsWire

SEC Filings (37)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 22, 2026424B3Offering prospectusDocumentIndex
Oct 22, 20268-KMaterial eventDocumentIndex
Sep 18, 2026EFFECTDocumentIndex
Sep 11, 2026S-1IPO / offering registrationDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Jul 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 9, 2026424B4Offering prospectusDocumentIndex
Jun 8, 2026EFFECTDocumentIndex
Jun 8, 2026CERTDocumentIndex
Jun 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 4, 2026S-1/AIPO / offering registrationDocumentIndex
Jun 1, 20268-A12BDocumentIndex
Jun 1, 2026S-1/AIPO / offering registrationDocumentIndex
Jun 1, 20268-KMaterial eventDocumentIndex
May 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 2026DEF 14CDocumentIndex
May 7, 2026S-1IPO / offering registrationDocumentIndex
May 5, 202610-QQuarterly reportDocumentIndex
May 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 1, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 28, 2026PRE 14CDocumentIndex
Mar 17, 202610-KAnnual reportDocumentIndex
Aug 14, 2025NT 10-QDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
May 15, 2025NT 10-QDocumentIndex
Apr 1, 2025NT 10-KDocumentIndex
Feb 21, 2025SEC STAFF ACTIONDocumentIndex
Nov 19, 2024NT 10-QDocumentIndex